NHS England Unveils Five-Year Genomic Healthcare Strategy
The new strategy places genomics at the heart of a new effort to deliver a sustainable model of healthcare for patients.
At the inaugural International Conference on Newborn Sequencing (ICoNS) in Boston last week, researchers outlined plans from eight studies in the US, the UK, Europe, and Australia.
The molecular diagnostics and bioinformatics firm reduced its 2022 forecast as it reported a 23 percent year-over-year revenue decline in Q2.
The diagnostics subsidiary, created by Oxford Nanopore Technologies last year, plans to forge partnerships with clinical and industry partners.
Stanford researchers said the cost of their approach is in line with Illumina sequencing but did not share data on error rate and other benchmarks at this time.